The impact of autoimmune comorbidities on the onset attack recovery in adults with AQP4-NMOSD and MOGAD.
Samadzadeh S. et al, (2025), J Neurol, 272
Sleep-related hypermotor epilepsy in a patient with myelin-oligodendrocyte-glycoprotein antibody disease.
Holm-Mercer L. et al, (2025), BMJ Case Rep, 18
Smoking status and vascular risk factors as predictors of disability in AQP4-NMOSD and MOGAD.
Chan F. et al, (2025), Mult Scler
Toward European harmonization of national myasthenia gravis registries: modified Delphi procedure-based expert consensus on collectable data.
Slioui A. et al, (2025), Orphanet J Rare Dis, 20
The role of N-glycans in regulatory T cells in autoimmunity.
Carneiro P. et al, (2025), Autoimmun Rev, 24
Quantitative Contribution of Clinical Attacks to Residual Disability in Patients With AQP4-Antibody Neuromyelitis Optica Spectrum Disorder.
Chen B. et al, (2025), Neurology, 104
Efgartigimod efficacy and safety in refractory myasthenia gravis: UK's first real-world experience.
Moniz Dionísio J. et al, (2025), J Neurol Neurosurg Psychiatry
Clinical data and reporting quality in NMDAR-antibody encephalitis and pregnancy: a systematic review.
Harris SL. et al, (2025), BMJ Neurol Open, 7
Daily self-injection of zilucoplan improved symptoms in people with generalized myasthenia gravis in the RAISE clinical study: a Plain Language Summary of Publication
Howard JF. et al, (2025), Future Neurology, 20
Progressive Encephalomyelitis with Rigidity and Myoclonus (PERM) Associated with GlyR Antibody in an APECED Patient.
Ochoa S. et al, (2024), J Clin Immunol, 45
The influence of MOGAD on diagnosis of multiple sclerosis using MRI.
Geraldes R. et al, (2024), Nat Rev Neurol
Retinal Changes in Double-Antibody Seronegative Neuromyelitis Optica Spectrum Disorders.
Oertel FC. et al, (2024), Neurol Neuroimmunol Neuroinflamm, 11
Study of seasonality of attacks in MOG antibody-associated disease.
Francis A. et al, (2024), Mult Scler Relat Disord, 90
Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis.
Arnett S. et al, (2024), J Neurol
Characterizing mortality in patients with AQP4-Ab+ neuromyelitis optica spectrum disorder.
Francis A. et al, (2024), Ann Clin Transl Neurol
MOG-IgA as a Potential Marker of Germinal Center Activity.
Handel AE. et al, (2024), JAMA Neurol, 81
Usability of the zilucoplan prefilled syringe for the treatment of generalized myasthenia gravis: insights from a human factors validation study
Domanska B. et al, (2024), Expert Review of Medical Devices